December 3, 2013
MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II DNA Sequencing System, today announced it is collaborating with the Wellcome Trust Sanger Institute and Public Health England to complete the sequences of 3,000 bacterial genome strains from PHE's National Collection of Type Cultures (NCTC). Sequencing will be performed [...]
Tute Genomics appoints Dr. Mingfu Zhu as Director of Bioinformatics
December 3, 2013
SALT LAKE CITY -- Dr. Mingfu Zhu, previously of the Duke Center for Human Genome Variation, has announced his new position with Tute Genomics as Director of Bioinformatics. Dr. Zhu's extensive work with structural variation analysis of next-generation sequencing (NGS) data from whole genomes places Tute ahead of other analytic engines in applying structural variant [...]
December 3, 2013
Mississauga, ON -- Therapure Biopharma Inc. and Upfront Chromatography A/S have announced today that they have entered into an agreement for Therapure to acquire the assets and associated business related to human plasma fractionation from Upfront. Upfront has developed over the last 15 years, a proprietary protein purification technology, based on Expanded Bed Adsorption (EBA) [...]
Agilent Technologies Introduces Next-Generation Atomic Force Microscope
December 3, 2013
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced the availability of its 7500 atomic force microscope (AFM), a highly advanced instrument that establishes new performance, functionality and ease-of-use benchmarks for nanoscale measurement, characterization and manipulation. The Agilent 7500 achieves atomic resolution imaging with its 90 m AFM closed-loop scanner. The Agilent 7500 [...]
December 3, 2013
Oxford Instruments announces the X-MET7500 Mining Analyser incorporating the latest detector technology, providing a superb combination of speed, flexibility and ease of use for on-site mining and soil analysis. The X-MET7500 Mining Analyser delivers the versatility of a laboratory, right there in the field, enabling fast and reliable analysis of the widest variety of materials, [...]
December 3, 2013
ST. LOUIS -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced its Supelco® brand has released Titan UHPLC columns manufactured using the Company's new cost-efficient, patent-pending Ecoporous™ silica manufacturing process. Starting at a list price of $300, Titan columns contain the first sub-2 micrometer porous silica that is monodisperse and high-performance ( > 250,000 plates per meter), [...]
December 3, 2013
Basel, Switzerland - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced its successful collaboration with AstraZeneca on data analysis for compound combination experiments. Drug combination studies, which are increasingly used in pre-clinical research, produce large volumes of data with upwards to 200 combinations per experiment. Genedata [...]
ImmunoChemistry Technologies Changes Ownership
December 3, 2013
Minneapolis, MN -- ImmunoChemistry Technologies (ICT), a Minnesota-based biotechnology company that supplies unique biochemical laboratory reagents and assay tests to medical researchers, has changed ownership. Now majority women-owned, ICT develops new products to help researchers discover new treatments and drugs for cancer and other diseases affecting both animals and humans. The privately held company is [...]
BioNano Genomics Announces the Adoption of Irys System by the Garvan Institute of Medical Research
December 3, 2013
SAN DIEGO and SYDNEY -- BioNano Genomics announced today the Garvan Institute of Medical Research has elected to incorporate the Irys technology into their disease research programs, with particular emphasis on improving understanding of prostate cancer. With their purchase of an Irys System, Garvan becomes the first Early Access user of the technology in Australia. [...]
Driving European Drug Discovery with Mosaic
December 3, 2013
LONDON, UK -- Leading sample management software provider, Titian Software, has announced that its Mosaic software is to play a central role in compound library screening for a major new European drug discovery initiative, the European Lead Factory (ELF). Following a successful bid to the Innovative Medicines Initiative (IMI), over 8.7m euros has been invested [...]
